Search

everythinglearnresearchcommunity

for

Search:↓

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Gene therapy shows promise for healing chronic wounds but needs more research to overcome challenges.

Regulating cell death in hair follicles can help prevent hair loss and promote hair growth.

Lactobacillus plantarum hydrolysates may help increase hair growth by boosting VEGF production.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

A condition with certain scalp changes may come before acne keloidalis nuchae and other similar hair loss disorders.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Lichen planopilaris involves disrupted fat metabolism, increased scarring, and mast cell activity.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Trichoscopy helps tell apart Lichen planopilaris and Frontal fibrosing alopecia from other hair loss conditions.

Trichoscopy helps effectively tell apart different types of patchy hair loss in Egyptian patients.

Stress may trigger hair loss by affecting immune protection in hair follicles.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

Hair transplants can lead to hair loss from lichen planopilaris, and patients should be tested and wait two years before the procedure.

Some people with primary cicatricial alopecia also have inflammatory bowel disease, suggesting a possible connection.

Hair transplants can cause hair loss if done while lichen planopilaris is active; wait until it's inactive for two years and check with a scalp biopsy first.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Lichen planopilaris mostly affects women with fair skin and can look different on each person, needing early treatment to prevent hair loss.

Platelet-Rich Plasma (PRP) may help improve hair density in primary cicatricial alopecias (PCAs) patients, but more trials are needed to confirm its benefits.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

The mTOR pathway proteins are altered in the hair follicles of patients with Lichen Planopilaris and Frontal Fibrosing Alopecia.

Lichen planopilaris is the most common type of scarring hair loss observed, with a variety of symptoms and tissue changes.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.